Biotechnology
The Biotechnology industry has a total of 609 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.25 billion.
Market Cap
1.12T
Revenue
105.25B
Profits
-42.73B
PE Ratio
n/a
Profit Margin
-40.60%
Dividend Yield
0.04%
609 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.02B | 0.33% | 750,548 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.05B | -0.56% | 618,329 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 59.61B | 1.37% | 563,872 | 3.21B |
| 4 | ARGX | argenx SE | 55.52B | -0.62% | 126,232 | 3.68B |
| 5 | INSM | Insmed Incorporated | 44.31B | 1.59% | 1,052,640 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 37.69B | -0.01% | 107,471 | 5.00B |
| 7 | BNTX | BioNTech SE | 24.80B | 0.44% | 822,253 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.10B | 0.45% | 1,619,199 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.51B | -1.13% | 932,388 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.50B | 1.38% | 2,352,034 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.03B | 0.23% | 850,027 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.47B | -0.19% | 2,345,700 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 13.88B | 0.40% | 524,469 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.80B | 0.39% | 1,388,930 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.56B | -0.67% | 116,259 | 740.64M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.40B | 0.04% | 852,944 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.97B | 1.10% | 273,565 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.89B | -0.09% | 1,528,537 | 2.29B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.80B | 0.13% | 1,074,967 | 20.87M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.74B | 0.74% | 1,266,602 | 3.09B |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.73B | -0.22% | 330,866 | 4.16B |
| 22 | MRNA | Moderna, Inc. | 10.15B | 3.88% | 4,286,459 | 2.23B |
| 23 | TECH | Bio-Techne Corporation | 10.05B | -0.19% | 867,038 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.46B | -0.68% | 369,233 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.40B | -1.73% | 1,090,683 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.35B | -0.50% | 201,501 | 741.17M |
| 27 | CYTK | Cytokinetics, Incorporated | 8.33B | -0.03% | 525,375 | 87.21M |
| 28 | NUVL | Nuvalent, Inc. | 7.94B | 0.12% | 327,690 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.64B | 0.34% | 189,517 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.29B | 0.05% | 394,310 | 56.61M |
| 31 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | 1.55% | 443,685 | 174.33M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.20B | 1.59% | 1,134,012 | 649.06M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.16B | -8.68% | 2,643,123 | 829.45M |
| 34 | CDTX | Cidara Therapeutics, Inc. | 6.91B | 0.06% | 490,934 | 302.00K |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.90B | -0.30% | 1,109,583 | 1.78B |
| 36 | PCVX | Vaxcyte, Inc. | 6.49B | -0.08% | 685,203 | - |
| 37 | KRYS | Krystal Biotech, Inc. | 6.32B | -0.32% | 76,546 | 373.16M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.12B | -0.42% | 1,086,559 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.63B | -0.08% | 337,396 | 209.22M |
| 40 | LEGN | Legend Biotech Corporation | 5.12B | 0.76% | 482,971 | 909.05M |
| 41 | CRSP | CRISPR Therapeutics AG | 5.10B | 0.32% | 1,406,530 | 38.34M |
| 42 | PRAX | Praxis Precision Medicines, Inc. | 4.91B | 4.20% | 708,641 | 7.46M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.87B | -0.29% | 450,021 | 43.74M |
| 44 | TGTX | TG Therapeutics, Inc. | 4.86B | -0.45% | 798,610 | 531.90M |
| 45 | APGE | Apogee Therapeutics, Inc. | 4.86B | 2.37% | 322,701 | - |
| 46 | BLTE | Belite Bio, Inc | 4.80B | 6.03% | 75,294 | - |
| 47 | NAMS | NewAmsterdam Pharma Company N.V. | 4.68B | -0.46% | 407,193 | 35.24M |
| 48 | CELC | Celcuity Inc. | 4.68B | 0.79% | 181,558 | - |
| 49 | ADMA | ADMA Biologics, Inc. | 4.56B | 0.21% | 1,258,119 | 488.56M |
| 50 | SRRK | Scholar Rock Holding Corporation | 4.49B | 2.04% | 690,122 | - |
| 51 | AKRO | Akero Therapeutics, Inc. | 4.48B | 0.02% | 638,112 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.32B | -0.87% | 726,786 | 1.54M |
| 53 | CNTA | Centessa Pharmaceuticals plc | 4.24B | 0.35% | 1,217,165 | 15.00M |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 4.24B | 0.93% | 563,252 | 1.05B |
| 55 | IMVT | Immunovant, Inc. | 4.23B | 1.90% | 523,946 | - |
| 56 | ACLX | Arcellx, Inc. | 4.20B | -0.82% | 560,265 | 35.90M |
| 57 | VKTX | Viking Therapeutics, Inc. | 4.16B | 1.49% | 1,187,031 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.75B | -1.00% | 1,090,812 | 317.93M |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 3.75B | -0.25% | 104,629 | 471.79M |
| 60 | CGON | CG Oncology, Inc. | 3.62B | -0.20% | 389,205 | 2.17M |
| 61 | IRON | Disc Medicine, Inc. | 3.52B | -0.53% | 248,702 | - |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 3.46B | 0.52% | 236,731 | 7.50M |
| 63 | MLYS | Mineralys Therapeutics, Inc. | 3.41B | -0.77% | 454,243 | - |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.39B | -0.12% | 120,659 | 366.10M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.38B | 2.05% | 34,754 | 664.23M |
| 66 | RARE | Ultragenyx Pharmaceutical Inc. | 3.35B | 2.93% | 785,180 | 630.60M |
| 67 | RCUS | Arcus Biosciences, Inc. | 3.23B | 2.11% | 675,978 | 240.00M |
| 68 | TVTX | Travere Therapeutics, Inc. | 3.17B | -2.34% | 761,345 | 435.83M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.13B | 3.45% | 2,258,428 | - |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 3.12B | -0.84% | 617,398 | 214.83M |
| 71 | FOLD | Amicus Therapeutics, Inc. | 3.06B | -0.90% | 1,609,447 | 598.70M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 3.05B | 0.76% | 651,613 | 70.79M |
| 73 | AAPG | Ascentage Pharma Group International | 3.03B | 1.18% | 749 | 54.52M |
| 74 | ADPT | Adaptive Biotechnologies Corporation | 3.00B | -0.30% | 926,835 | 252.75M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.88B | -0.09% | 527,443 | 578.20M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.86B | 0.36% | 1,088,610 | - |
| 77 | LQDA | Liquidia Corporation | 2.84B | 2.87% | 681,313 | 69.22M |
| 78 | EWTX | Edgewise Therapeutics, Inc. | 2.76B | 2.12% | 479,577 | - |
| 79 | NUVB | Nuvation Bio Inc. | 2.75B | 0.25% | 3,191,839 | 26.75M |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.71B | 1.61% | 883,650 | 98.68M |
| 81 | APLS | Apellis Pharmaceuticals, Inc. | 2.69B | -1.27% | 1,108,373 | 1.02B |
| 82 | OCUL | Ocular Therapeutix, Inc. | 2.59B | 0.08% | 1,229,227 | 55.78M |
| 83 | TERN | Terns Pharmaceuticals, Inc. | 2.53B | -2.23% | 1,027,032 | - |
| 84 | BEAM | Beam Therapeutics Inc. | 2.50B | 1.20% | 837,282 | 55.70M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.41B | 4.99% | 10,565,583 | 43.69M |
| 86 | SYRE | Spyre Therapeutics, Inc. | 2.33B | 0.84% | 562,693 | - |
| 87 | IBRX | ImmunityBio, Inc. | 2.32B | 10.80% | 21,332,657 | 82.56M |
| 88 | MESO | Mesoblast Limited | 2.28B | -0.98% | 191,863 | 17.20M |
| 89 | ZLAB | Zai Lab Limited | 2.26B | 2.20% | 211,500 | 441.63M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.24B | 1.86% | 1,633,037 | 2.41B |
| 91 | OLMA | Olema Pharmaceuticals, Inc. | 2.23B | 0.71% | 1,099,171 | - |
| 92 | GPCR | Structure Therapeutics Inc. | 2.17B | 4.65% | 648,987 | - |
| 93 | VERA | Vera Therapeutics, Inc. | 2.16B | 1.26% | 649,316 | - |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -1.53% | 860,793 | 265.81M |
| 95 | ZBIO | Zenas BioPharma, Inc. | 2.08B | -4.19% | 166,011 | 15.00M |
| 96 | GLPG | Galapagos NV | 2.07B | 0.61% | 40,975 | 336.64M |
| 97 | JANX | Janux Therapeutics, Inc. | 2.05B | -1.73% | 675,707 | 10.00M |
| 98 | VCEL | Vericel Corporation | 2.04B | -0.33% | 183,885 | 258.72M |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 2.03B | -0.76% | 256,407 | 825.94M |
| 100 | ZYME | Zymeworks Inc. | 2.00B | -2.27% | 578,114 | 134.48M |
| 101 | IMCR | Immunocore Holdings plc | 2.00B | -1.57% | 133,880 | 379.59M |
| 102 | SION | Sionna Therapeutics, Inc. | 1.94B | -0.55% | 222,839 | - |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.89B | -0.23% | 242,147 | 3.08M |
| 104 | PHVS | Pharvaris N.V. | 1.83B | 1.89% | 163,777 | - |
| 105 | MAZE | Maze Therapeutics, Inc. | 1.82B | -0.66% | 200,078 | 2.50M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.80B | 0.63% | 292,050 | 2.60M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.79B | 2.79% | 906,820 | 83.69M |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.77B | -0.96% | 461,599 | 205.63M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -0.25% | 852,288 | 111.30M |
| 110 | QURE | uniQure N.V. | 1.71B | -0.43% | 612,857 | 15.75M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.70B | 0.55% | 500,589 | 44.79M |
| 112 | TRVI | Trevi Therapeutics, Inc. | 1.69B | -0.75% | 1,328,442 | - |
| 113 | IMNM | Immunome, Inc. | 1.69B | -1.10% | 328,589 | 9.68M |
| 114 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | -0.13% | 421,441 | -665.00K |
| 115 | MNKD | MannKind Corporation | 1.64B | -0.56% | 796,201 | 313.79M |
| 116 | INVA | Innoviva, Inc. | 1.62B | 0.05% | 360,174 | 388.52M |
| 117 | MBX | MBX Biosciences, Inc. | 1.55B | 1.98% | 255,175 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.55B | 2.14% | 145,017 | 2.80M |
| 119 | SVRA | Savara Inc. | 1.52B | 17.35% | 6,552,886 | - |
| 120 | TNGX | Tango Therapeutics, Inc. | 1.47B | 1.39% | 1,203,623 | 66.50M |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.46B | -1.15% | 175,053 | - |
| 122 | ARDX | Ardelyx, Inc. | 1.41B | -1.94% | 1,061,442 | 398.23M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.40B | 0.14% | 281,949 | - |
| 124 | RLAY | Relay Therapeutics, Inc. | 1.37B | -1.37% | 763,552 | 8.36M |
| 125 | PGEN | Precigen, Inc. | 1.36B | 2.41% | 1,775,549 | 6.31M |
| 126 | URGN | UroGen Pharma Ltd. | 1.35B | -2.24% | 379,784 | 96.52M |
| 127 | BHVN | Biohaven Ltd. | 1.33B | 5.80% | 1,750,454 | - |
| 128 | NKTR | Nektar Therapeutics | 1.33B | -0.73% | 307,035 | 62.60M |
| 129 | IMTX | Immatics N.V. | 1.30B | 0.75% | 757,987 | 99.45M |
| 130 | SEPN | Septerna, Inc. | 1.30B | -1.69% | 295,178 | 22.05M |
| 131 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -2.47% | 1,117,120 | 6.31M |
| 132 | WVE | Wave Life Sciences Ltd. | 1.30B | 1.17% | 1,487,798 | 109.23M |
| 133 | ELVN | Enliven Therapeutics, Inc. | 1.28B | -0.55% | 252,891 | - |
| 134 | MNMD | Mind Medicine (MindMed) Inc. | 1.25B | 4.55% | 928,005 | - |
| 135 | XNCR | Xencor, Inc. | 1.24B | -0.35% | 214,164 | 150.13M |
| 136 | CVAC | CureVac N.V. | 1.24B | 0.18% | 5,370,646 | 83.00M |
| 137 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.23B | 0.07% | 331,316 | 42.34M |
| 138 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 0.55% | 123,586 | 1.40M |
| 139 | PVLA | Palvella Therapeutics, Inc. | 1.22B | 2.80% | 229,925 | - |
| 140 | KOD | Kodiak Sciences Inc. | 1.22B | 2.41% | 266,533 | - |
| 141 | TYRA | Tyra Biosciences, Inc. | 1.20B | 2.32% | 273,312 | - |
| 142 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | - | 944,530 | 266.14M |
| 143 | FTRE | Fortrea Holdings Inc. | 1.17B | 0.71% | 515,568 | 2.76B |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.16B | 0.25% | 603,072 | - |
| 145 | ANAB | AnaptysBio, Inc. | 1.15B | -1.21% | 234,280 | 169.47M |
| 146 | NVAX | Novavax, Inc. | 1.15B | 1.44% | 1,521,954 | 1.06B |
| 147 | SANA | Sana Biotechnology, Inc. | 1.15B | 6.97% | 3,912,944 | - |
| 148 | PHAR | Pharming Group N.V. | 1.14B | -5.30% | 28,400 | 362.27M |
| 149 | ABCL | AbCellera Biologics Inc. | 1.12B | 2.47% | 4,423,872 | 35.33M |
| 150 | OCS | Oculis Holding AG | 1.10B | 0.48% | 100,877 | 992.00K |
| 151 | PHAT | Phathom Pharmaceuticals, Inc. | 1.09B | 2.97% | 765,735 | 147.19M |
| 152 | KURA | Kura Oncology, Inc. | 1.06B | 1.25% | 635,589 | 104.03M |
| 153 | GLUE | Monte Rosa Therapeutics, Inc. | 1.05B | 1.19% | 592,223 | 181.54M |
| 154 | NTLA | Intellia Therapeutics, Inc. | 1.04B | 5.52% | 3,694,186 | 57.53M |
| 155 | CMPX | Compass Therapeutics, Inc. | 1.03B | 7.61% | 1,519,828 | 850.00K |
| 156 | TBPH | Theravance Biopharma, Inc. | 1.03B | 1.70% | 502,343 | 80.33M |
| 157 | BCAX | Bicara Therapeutics Inc. | 1.02B | -2.32% | 256,603 | - |
| 158 | MDXG | MiMedx Group, Inc. | 1.02B | -0.22% | 341,776 | 393.44M |
| 159 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 984.66M | 1.07% | 38,000 | - |
| 160 | IOVA | Iovance Biotherapeutics, Inc. | 980.51M | 1.23% | 3,422,899 | 250.43M |
| 161 | MLTX | MoonLake Immunotherapeutics | 979.96M | -0.51% | 915,626 | - |
| 162 | DAWN | Day One Biopharmaceuticals, Inc. | 974.39M | 0.85% | 930,796 | 133.67M |
| 163 | NBTX | Nanobiotix S.A. | 970.57M | - | 29,248 | 11.93M |
| 164 | LENZ | LENZ Therapeutics, Inc. | 954.97M | -1.11% | 117,534 | 17.50M |
| 165 | AVBP | ArriVent BioPharma, Inc. | 946.99M | -0.30% | 126,560 | - |
| 166 | SPRY | ARS Pharmaceuticals, Inc. | 943.02M | -0.31% | 848,573 | 142.77M |
| 167 | GHRS | GH Research PLC | 940.37M | 2.78% | 177,701 | - |
| 168 | RAPT | RAPT Therapeutics, Inc. | 936.63M | 1.17% | 353,048 | - |
| 169 | MRVI | Maravai LifeSciences Holdings, Inc. | 925.66M | -0.55% | 427,557 | 192.44M |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 916.46M | -0.92% | 275,703 | 282.08M |
| 171 | RZLT | Rezolute, Inc. | 901.31M | 1.67% | 733,511 | - |
| 172 | ERAS | Erasca, Inc. | 899.37M | 1.28% | 1,285,262 | - |
| 173 | VIR | Vir Biotechnology, Inc. | 893.18M | 0.47% | 813,271 | 16.86M |
| 174 | ABUS | Arbutus Biopharma Corporation | 848.15M | -0.11% | 395,650 | 14.61M |
| 175 | ATAI | Atai Beckley N.V. | 833.78M | 3.73% | 2,274,173 | 3.02M |
| 176 | VSTM | Verastem, Inc. | 821.22M | 0.09% | 649,950 | 13.38M |
| 177 | YDES | YD Bio Limited | 810.79M | 9.60% | 49,922 | 510.36K |
| 178 | ARVN | Arvinas, Inc. | 808.26M | 1.33% | 630,969 | 312.30M |
| 179 | VALN | Valneva SE | 801.30M | -1.94% | 20,190 | 211.09M |
| 180 | ALMS | Alumis Inc. | 800.70M | 0.39% | 493,844 | 22.12M |
| 181 | REPL | Replimune Group, Inc. | 784.43M | -0.60% | 855,213 | - |
| 182 | GOSS | Gossamer Bio, Inc. | 773.06M | - | 1,136,691 | 44.05M |
| 183 | CRMD | CorMedix Inc. | 772.92M | 1.66% | 988,005 | 214.30M |
| 184 | GERN | Geron Corporation | 753.26M | -1.26% | 4,206,990 | 183.40M |
| 185 | KALV | KalVista Pharmaceuticals, Inc. | 731.40M | 2.38% | 719,084 | 1.43M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 725.18M | 1.30% | 694,264 | 113.63M |
| 187 | ATXS | Astria Therapeutics, Inc. | 722.12M | 0.40% | 532,793 | 706.00K |
| 188 | LXEO | Lexeo Therapeutics, Inc. | 719.66M | 2.39% | 986,966 | - |
| 189 | VTYX | Ventyx Biosciences, Inc. | 713.59M | 0.05% | 382,928 | - |
| 190 | GYRE | Gyre Therapeutics, Inc. | 704.40M | -0.64% | 26,672 | 107.27M |
| 191 | OMER | Omeros Corporation | 687.03M | 0.62% | 594,031 | - |
| 192 | CRVS | Corvus Pharmaceuticals, Inc. | 684.83M | 0.88% | 460,754 | - |
| 193 | RGNX | REGENXBIO Inc. | 677.84M | 0.98% | 1,097,378 | 161.32M |
| 194 | PRME | Prime Medicine, Inc. | 676.29M | 2.96% | 2,155,201 | 5.98M |
| 195 | CGEM | Cullinan Therapeutics, Inc. | 671.70M | -3.15% | 612,155 | - |
| 196 | MGTX | MeiraGTx Holdings plc | 668.07M | 1.16% | 349,312 | 27.42M |
| 197 | PROK | ProKidney Corp. | 667.85M | 4.72% | 1,126,447 | 744.00K |
| 198 | FDMT | 4D Molecular Therapeutics, Inc. | 666.19M | 6.10% | 845,188 | 120.00K |
| 199 | ANNX | Annexon, Inc. | 651.28M | 4.17% | 1,762,644 | - |
| 200 | EVMN | Evommune, Inc. | 622.91M | 6.70% | 50,627 | 3.00M |
| 201 | MPLT | MapLight Therapeutics, Inc. | 594.83M | 4.93% | 136,123 | - |
| 202 | ASMB | Assembly Biosciences, Inc. | 592.11M | 0.66% | 28,336 | 37.19M |
| 203 | FULC | Fulcrum Therapeutics, Inc. | 592.06M | -3.27% | 409,339 | 80.00M |
| 204 | IVA | Inventiva S.A. | 590.55M | -7.61% | 175,026 | 19.93M |
| 205 | JBIO | Jade Biosciences, Inc. | 589.77M | 2.96% | 100,425 | - |
| 206 | PRTA | Prothena Corporation plc | 578.67M | 2.97% | 288,728 | 11.79M |
| 207 | MNPR | Monopar Therapeutics Inc. | 575.91M | -1.35% | 82,436 | - |
| 208 | IVVD | Invivyd, Inc. | 566.49M | 4.29% | 1,758,711 | 50.04M |
| 209 | ALT | Altimmune, Inc. | 548.84M | 1.74% | 2,118,874 | 20.00K |
| 210 | NAGE | Niagen Bioscience, Inc. | 542.20M | -1.89% | 331,957 | 124.71M |
| 211 | DSGN | Design Therapeutics, Inc. | 534.89M | 0.21% | 124,213 | - |
| 212 | ADCT | ADC Therapeutics SA | 532.67M | -0.69% | 254,910 | 75.21M |
| 213 | DRUG | Bright Minds Biosciences Inc. | 532.55M | 6.88% | 53,858 | - |
| 214 | KROS | Keros Therapeutics, Inc. | 532.55M | -0.11% | 660,545 | 246.72M |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 527.44M | 1.87% | 446,102 | 180.61M |
| 216 | ENGN | enGene Holdings Inc. | 521.15M | -2.18% | 398,589 | - |
| 217 | LXRX | Lexicon Pharmaceuticals, Inc. | 519.66M | - | 723,546 | 70.86M |
| 218 | BCYC | Bicycle Therapeutics plc | 518.87M | 2.33% | 238,829 | 28.34M |
| 219 | LYEL | Lyell Immunopharma, Inc. | 509.24M | 3.24% | 53,723 | 41.00K |
| 220 | IMRX | Immuneering Corporation | 494.61M | 2.00% | 682,687 | - |
| 221 | ABSI | Absci Corporation | 476.68M | 2.59% | 1,453,352 | 2.82M |
| 222 | DBVT | DBV Technologies S.A. | 476.05M | 1.20% | 617,165 | 5.50M |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 474.59M | -1.40% | 567,801 | 84.39M |
| 224 | LBRX | LB Pharmaceuticals Inc | 450.07M | 7.08% | 131,773 | - |
| 225 | DMAC | DiaMedica Therapeutics Inc. | 449.43M | -5.37% | 239,876 | - |
| 226 | PEPG | PepGen Inc. | 442.74M | 5.75% | 920,104 | - |
| 227 | NBP | NovaBridge Biosciences | 442.62M | -0.52% | 266,387 | - |
| 228 | BNTC | Benitec Biopharma Inc. | 438.85M | -0.54% | 48,998 | - |
| 229 | ANRO | Alto Neuroscience, Inc. | 430.27M | 2.52% | 278,696 | - |
| 230 | LCTX | Lineage Cell Therapeutics, Inc. | 426.50M | 2.92% | 1,383,279 | 10.82M |
| 231 | SLDB | Solid Biosciences Inc. | 423.05M | 1.31% | 304,429 | - |
| 232 | AURA | Aura Biosciences, Inc. | 419.12M | 3.45% | 215,263 | - |
| 233 | ENTA | Enanta Pharmaceuticals, Inc. | 407.54M | 1.94% | 143,060 | 65.32M |
| 234 | PRTC | PureTech Health plc | 403.11M | 3.62% | 3,443 | 6.39M |
| 235 | TECX | Tectonic Therapeutic, Inc. | 401.28M | 0.42% | 115,292 | - |
| 236 | XOMA | XOMA Royalty Corporation | 397.87M | -0.50% | 21,089 | 47.11M |
| 237 | OCGN | Ocugen, Inc. | 387.28M | 5.08% | 2,700,835 | 5.37M |
| 238 | TENX | Tenax Therapeutics, Inc. | 382.58M | -0.84% | 58,641 | - |
| 239 | AUTL | Autolus Therapeutics plc | 375.26M | 2.92% | 1,460,491 | 51.13M |
| 240 | NMRA | Neumora Therapeutics, Inc. | 374.28M | -1.97% | 419,683 | - |
| 241 | CLLS | Cellectis S.A. | 371.94M | 0.79% | 47,045 | 82.55M |
| 242 | RCKT | Rocket Pharmaceuticals, Inc. | 370.12M | 3.95% | 1,106,867 | - |
| 243 | GALT | Galectin Therapeutics Inc. | 369.43M | -0.52% | 101,423 | - |
| 244 | TRDA | Entrada Therapeutics, Inc. | 368.30M | 1.39% | 141,405 | 61.52M |
| 245 | AVTX | Avalo Therapeutics, Inc. | 344.55M | 2.43% | 187,672 | 192.00K |
| 246 | AVXL | Anavex Life Sciences Corp. | 342.20M | -0.78% | 1,682,915 | - |
| 247 | DRTS | Alpha Tau Medical Ltd. | 338.50M | 6.15% | 28,153 | - |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 335.92M | -0.13% | 208,723 | - |
| 249 | VTVT | vTv Therapeutics Inc. | 331.32M | -1.11% | - | 17.00K |
| 250 | FBRX | Forte Biosciences, Inc. | 330.95M | -3.62% | 79,533 | - |
| 251 | RLMD | Relmada Therapeutics, Inc. | 330.73M | 7.40% | 341,233 | - |
| 252 | ALDX | Aldeyra Therapeutics, Inc. | 329.69M | -1.79% | 626,822 | - |
| 253 | NGNE | Neurogene Inc. | 329.00M | 1.19% | 217,403 | 925.00K |
| 254 | ALLO | Allogene Therapeutics, Inc. | 328.11M | 2.82% | 1,404,792 | 22.00K |
| 255 | PYXS | Pyxis Oncology, Inc. | 323.15M | -1.70% | 324,659 | 2.82M |
| 256 | CTNM | Contineum Therapeutics, Inc. | 323.05M | 3.16% | 76,319 | - |
| 257 | SLN | Silence Therapeutics plc | 318.36M | -1.46% | 138,709 | 25.83M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 318.27M | - | 240,502 | 33.98M |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 316.76M | 1.13% | 574,498 | 212.07M |
| 260 | EPRX | Eupraxia Pharmaceuticals Inc. | 316.49M | 0.80% | 30,927 | - |
| 261 | PALI | Palisade Bio, Inc. | 314.40M | -5.38% | 2,557,458 | - |
| 262 | CYBN | Cybin Inc. | 308.40M | 2.49% | 434,532 | - |
| 263 | ACRS | Aclaris Therapeutics, Inc. | 306.62M | -1.74% | 503,820 | 15.74M |
| 264 | LRMR | Larimar Therapeutics, Inc. | 302.99M | 0.28% | 812,579 | - |
| 265 | OBIO | Orchestra BioMed Holdings, Inc. | 300.39M | 1.53% | 122,539 | 2.82M |
| 266 | MREO | Mereo BioPharma Group plc | 297.58M | 1.63% | 602,219 | 500.00K |
| 267 | ACIU | AC Immune SA | 295.84M | 1.71% | 53,286 | 5.48M |
| 268 | CBIO | Crescent Biopharma, Inc. | 294.22M | -1.76% | - | - |
| 269 | IMMP | Immutep Limited | 293.96M | 6.88% | 161,156 | 3.31M |
| 270 | TARA | Protara Therapeutics, Inc. | 284.77M | -0.40% | 309,790 | - |
| 271 | NAUT | Nautilus Biotechnology, Inc. | 284.19M | -0.88% | 114,811 | - |
| 272 | FENC | Fennec Pharmaceuticals Inc. | 279.72M | 3.80% | 110,742 | 38.79M |
| 273 | ABEO | Abeona Therapeutics Inc. | 274.75M | -1.55% | 525,411 | 400.00K |
| 274 | MIST | Milestone Pharmaceuticals Inc. | 273.26M | 3.07% | 3,272,039 | - |
| 275 | FHTX | Foghorn Therapeutics Inc. | 268.62M | -1.87% | 50,532 | 24.52M |
| 276 | ARMP | Armata Pharmaceuticals, Inc. | 266.30M | 1.52% | 22,739 | 5.05M |
| 277 | CCCC | C4 Therapeutics, Inc. | 262.64M | 1.12% | 714,400 | 30.11M |
| 278 | CADL | Candel Therapeutics, Inc. | 261.86M | 3.25% | 478,073 | - |
| 279 | OABI | OmniAb, Inc. | 260.56M | -2.42% | 234,653 | 21.09M |
| 280 | ACHV | Achieve Life Sciences, Inc. | 259.25M | 0.62% | 329,537 | - |
| 281 | PBYI | Puma Biotechnology, Inc. | 254.48M | - | 155,189 | 212.00M |
| 282 | HUMA | Humacyte, Inc. | 252.82M | 1.50% | 2,268,872 | 1.57M |
| 283 | ZURA | Zura Bio Limited | 249.69M | 0.79% | 225,225 | - |
| 284 | CABA | Cabaletta Bio, Inc. | 247.40M | 8.44% | 2,607,002 | - |
| 285 | PRQR | ProQR Therapeutics N.V. | 246.51M | -0.85% | 205,846 | 18.86M |
| 286 | CAPR | Capricor Therapeutics, Inc. | 244.59M | 3.08% | 1,773,564 | 11.13M |
| 287 | AVIR | Atea Pharmaceuticals, Inc. | 242.19M | 1.64% | 146,205 | - |
| 288 | EDIT | Editas Medicine, Inc. | 235.26M | 0.42% | 1,016,115 | 46.38M |
| 289 | SGMT | Sagimet Biosciences Inc. | 234.81M | 1.98% | 211,874 | - |
| 290 | TNYA | Tenaya Therapeutics, Inc. | 233.11M | 2.94% | 1,379,747 | - |
| 291 | SLS | SELLAS Life Sciences Group, Inc. | 230.76M | 10.96% | 2,140,876 | - |
| 292 | MDWD | MediWound Ltd. | 229.76M | -0.39% | 53,412 | 20.93M |
| 293 | ETHZ | ETHZilla Corporation | 228.54M | 0.56% | 355,652 | 4.11M |
| 294 | VYGR | Voyager Therapeutics, Inc. | 227.40M | 1.49% | 261,094 | 31.32M |
| 295 | BDTX | Black Diamond Therapeutics, Inc. | 217.64M | 1.06% | 641,235 | 70.00M |
| 296 | AARD | Aardvark Therapeutics, Inc. | 217.30M | 3.21% | 134,146 | - |
| 297 | GUTS | Fractyl Health, Inc. | 215.16M | 6.08% | 1,892,753 | 3.00K |
| 298 | TLSA | Tiziana Life Sciences Ltd | 213.88M | - | 79,988 | - |
| 299 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 213.82M | -3.16% | 199,008 | - |
| 300 | HRTX | Heron Therapeutics, Inc. | 212.70M | 3.57% | 769,861 | 155.10M |
| 301 | GNLX | Genelux Corporation | 209.16M | -0.54% | 107,487 | 8.00K |
| 302 | QNCX | Quince Therapeutics, Inc. | 203.24M | 5.80% | 1,043,453 | - |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 194.77M | -1.45% | 45,216 | 1.09M |
| 304 | RANI | Rani Therapeutics Holdings, Inc. | 194.42M | -1.23% | 1,323,749 | 1.20M |
| 305 | VTGN | Vistagen Therapeutics, Inc. | 193.53M | 7.93% | 544,577 | 721.00K |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.92M | -0.15% | 302,007 | 97.60M |
| 307 | TNXP | Tonix Pharmaceuticals Holding Corp. | 188.07M | 5.90% | 281,146 | 10.30M |
| 308 | SABS | SAB Biotherapeutics, Inc. | 187.09M | -2.72% | 232,878 | 114.70K |
| 309 | IPHA | Innate Pharma S.A. | 186.81M | 3.17% | 11,208 | 14.84M |
| 310 | CAMP | Camp4 Therapeutics Corporation | 181.43M | 6.91% | 37,653 | 3.80M |
| 311 | CRBU | Caribou Biosciences, Inc. | 181.33M | 3.19% | 407,372 | 9.30M |
| 312 | ACTU | Actuate Therapeutics, Inc. | 177.35M | 10.00% | 54,912 | - |
| 313 | NTHI | NeOnc Technologies Holdings, Inc. | 174.30M | 5.48% | 39,022 | 59.99K |
| 314 | VOR | Vor Biopharma Inc. | 170.02M | 4.78% | 293,612 | - |
| 315 | CHRS | Coherus Oncology, Inc. | 164.38M | 3.82% | 750,018 | 277.73M |
| 316 | ELTX | Elicio Therapeutics, Inc. | 163.57M | 1.86% | 37,108 | - |
| 317 | MCRB | Seres Therapeutics, Inc. | 162.75M | 6.64% | 169,663 | 351.00K |
| 318 | NVCT | Nuvectis Pharma, Inc. | 158.81M | 2.31% | 77,466 | - |
| 319 | CNTB | Connect Biopharma Holdings Limited | 157.09M | -0.71% | 213,309 | 762.00K |
| 320 | SAVA | Cassava Sciences, Inc. | 157.00M | -4.13% | 845,538 | - |
| 321 | CDXS | Codexis, Inc. | 156.26M | -0.86% | 569,523 | 52.93M |
| 322 | SGMO | Sangamo Therapeutics, Inc. | 155.12M | -0.67% | 2,804,378 | 32.88M |
| 323 | AGEN | Agenus Inc. | 155.08M | 0.22% | 186,171 | 106.83M |
| 324 | CGTX | Cognition Therapeutics, Inc. | 153.60M | 5.45% | 673,220 | - |
| 325 | CRDF | Cardiff Oncology, Inc. | 153.58M | -2.56% | 339,633 | 501.00K |
| 326 | ANIX | Anixa Biosciences, Inc. | 151.09M | -1.29% | 87,591 | - |
| 327 | MOLN | Molecular Partners AG | 148.88M | 0.53% | - | 856.30K |
| 328 | IRD | Opus Genetics, Inc. | 146.89M | 5.45% | 265,145 | 14.63M |
| 329 | CGEN | Compugen Ltd. | 146.38M | -1.57% | 132,777 | 6.90M |
| 330 | ALEC | Alector, Inc. | 145.17M | -1.48% | 569,033 | 69.05M |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 143.15M | -2.73% | 294,185 | 61.84M |
| 332 | IMMX | Immix Biopharma, Inc. | 142.71M | -1.16% | 95,382 | - |
| 333 | INO | Inovio Pharmaceuticals, Inc. | 141.53M | 5.10% | 593,498 | 182.34K |
| 334 | UNCY | Unicycive Therapeutics, Inc. | 139.05M | 2.70% | 336,146 | - |
| 335 | PRLD | Prelude Therapeutics Incorporated | 138.43M | -1.20% | 370,862 | 10.50M |
| 336 | SRZN | Surrozen, Inc. | 137.66M | -2.37% | 33,280 | 3.60M |
| 337 | NBY | NovaBay Pharmaceuticals, Inc. | 137.35M | 6.86% | 88,912 | 10.30M |
| 338 | MRSN | Mersana Therapeutics, Inc. | 137.12M | -0.29% | 34,101 | 33.18M |
| 339 | COYA | Coya Therapeutics, Inc. | 136.22M | 2.04% | 150,321 | 3.99M |
| 340 | SPRO | Spero Therapeutics, Inc. | 135.21M | 3.00% | 136,577 | 40.55M |
| 341 | ANVS | Annovis Bio, Inc. | 135.16M | 3.66% | 1,286,769 | - |
| 342 | NKTX | Nkarta, Inc. | 134.25M | 3.28% | 528,878 | - |
| 343 | STTK | Shattuck Labs, Inc. | 132.89M | -2.35% | 39,022 | 1.00M |
| 344 | FATE | Fate Therapeutics, Inc. | 131.50M | 3.64% | 771,991 | 7.14M |
| 345 | DTIL | Precision BioSciences, Inc. | 130.95M | 6.46% | 90,196 | 698.00K |
| 346 | ACOG | Alpha Cognition Inc. | 130.89M | 0.66% | 24,550 | 7.43M |
| 347 | EXOZ | eXoZymes, Inc. | 130.00M | 1.24% | 1,757 | -700.00 |
| 348 | CLYM | Climb Bio, Inc. | 128.87M | 2.72% | 176,052 | - |
| 349 | GANX | Gain Therapeutics, Inc. | 126.84M | 11.46% | 1,423,982 | - |
| 350 | OVID | Ovid Therapeutics Inc. | 126.76M | 9.20% | 3,180,294 | 6.61M |
| 351 | ELDN | Eledon Pharmaceuticals, Inc. | 122.49M | 5.16% | 729,060 | - |
| 352 | GLSI | Greenwich LifeSciences, Inc. | 120.95M | 4.55% | 50,716 | - |
| 353 | CNTX | Context Therapeutics Inc. | 119.38M | - | 94,599 | - |
| 354 | SLGL | Sol-Gel Technologies Ltd. | 118.16M | 5.68% | - | 18.97M |
| 355 | KLRS | Kalaris Therapeutics, Inc. | 116.70M | -3.26% | 116,661 | - |
| 356 | ABOS | Acumen Pharmaceuticals, Inc. | 114.79M | -2.82% | 53,323 | - |
| 357 | IKT | Inhibikase Therapeutics, Inc. | 114.27M | -1.30% | 253,995 | 1.00 |
| 358 | ORMP | Oramed Pharmaceuticals Inc. | 113.44M | - | 162,998 | 2.00M |
| 359 | WHWK | Whitehawk Therapeutics, Inc. | 110.28M | 1.74% | 253,502 | 14.38M |
| 360 | ENTX | Entera Bio Ltd. | 109.14M | - | 39,206 | 124.00K |
| 361 | SEER | Seer, Inc. | 107.11M | -1.03% | 29,079 | 16.38M |
| 362 | SPRB | Spruce Biosciences, Inc. | 107.04M | -9.09% | 66,810 | 697.00K |
| 363 | ATRA | Atara Biotherapeutics, Inc. | 105.99M | -1.08% | 17,984 | 151.93M |
| 364 | ONCY | Oncolytics Biotech Inc. | 105.81M | -4.15% | 1,424,726 | - |
| 365 | ACET | Adicet Bio, Inc. | 104.81M | 7.85% | 1,315,741 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 103.68M | -0.35% | 289,002 | 26.87M |
| 367 | TTRX | Turn Therapeutics Inc. | 103.65M | 2.94% | 20,246 | - |
| 368 | HURA | TuHURA Biosciences, Inc. | 102.52M | -4.31% | 88,723 | - |
| 369 | COEP | Coeptis Therapeutics Holdings, Inc. | 100.82M | 0.43% | - | 501.00K |
| 370 | ATOS | Atossa Therapeutics, Inc. | 100.43M | -0.29% | 238,436 | - |
| 371 | VANI | Vivani Medical, Inc. | 99.22M | - | 51,109 | - |
| 372 | PLRX | Pliant Therapeutics, Inc. | 98.93M | 1.90% | 1,000,745 | - |
| 373 | MGNX | MacroGenics, Inc. | 96.79M | 3.38% | 366,150 | 127.63M |
| 374 | ANEB | Anebulo Pharmaceuticals, Inc. | 96.14M | - | 2,600 | - |
| 375 | KPTI | Karyopharm Therapeutics Inc. | 95.83M | 1.26% | 45,688 | 142.53M |
| 376 | HYFT | MindWalk Holdings Corp. | 95.08M | 7.29% | 346,296 | 18.21M |
| 377 | ADAG | Adagene Inc. | 94.73M | -5.19% | 38,793 | 103.20K |
| 378 | RPTX | Repare Therapeutics Inc. | 93.71M | -0.90% | 128,570 | 11.87M |
| 379 | ARTV | Artiva Biotherapeutics, Inc. | 92.29M | 5.03% | 66,099 | 251.00K |
| 380 | CRVO | CervoMed Inc. | 91.97M | - | 70,162 | 6.16M |
| 381 | THAR | Tharimmune, Inc. | 91.12M | 1.56% | 341,784 | - |
| 382 | ADVM | Adverum Biotechnologies, Inc. | 90.96M | -0.96% | 103,523 | 1.00M |
| 383 | CSBR | Champions Oncology, Inc. | 89.62M | - | 2,133 | 56.88M |
| 384 | VXRT | Vaxart, Inc. | 88.64M | 3.06% | 303,061 | 148.20M |
| 385 | TVGN | Tevogen Bio Holdings Inc. | 87.66M | -8.27% | 328,905 | - |
| 386 | FBIO | Fortress Biotech, Inc. | 87.53M | 2.17% | 242,976 | 62.30M |
| 387 | BYSI | BeyondSpring Inc. | 87.18M | 2.39% | 19,977 | 1.88M |
| 388 | PTHS | Pelthos Therapeutics Inc. | 86.95M | -0.35% | 31,082 | 7.41M |
| 389 | TIL | Instil Bio, Inc. | 86.54M | 6.51% | 23,808 | - |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 86.36M | 35.62% | 2,621,254 | 30.83M |
| 391 | IMUX | Immunic, Inc. | 85.63M | 1.55% | 943,112 | - |
| 392 | IFRX | InflaRx N.V. | 85.36M | 5.88% | 611,400 | 73.73K |
| 393 | PSTV | Plus Therapeutics, Inc. | 83.83M | 1.96% | 3,427,730 | 5.26M |
| 394 | ESLA | Estrella Immunopharma, Inc. | 79.69M | 12.23% | 104,091 | - |
| 395 | OTLK | Outlook Therapeutics, Inc. | 79.51M | 6.55% | 1,418,665 | 1.51M |
| 396 | STRO | Sutro Biopharma, Inc. | 78.27M | 3.73% | 223,746 | 105.65M |
| 397 | BMEA | Biomea Fusion, Inc. | 77.07M | 1.87% | 690,764 | - |
| 398 | ATYR | aTyr Pharma, Inc. | 76.48M | 2.00% | 977,280 | 190.00K |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 74.47M | - | 294,952 | - |
| 400 | ALXO | ALX Oncology Holdings Inc. | 74.28M | -1.45% | 42,778 | - |
| 401 | CBUS | Cibus, Inc. | 73.83M | 3.03% | 143,415 | 3.79M |
| 402 | OKYO | OKYO Pharma Limited | 73.72M | 0.51% | 62,518 | - |
| 403 | IMA | ImageneBio, Inc. | 73.49M | -0.14% | 13,272 | 800.00K |
| 404 | MNOV | MediciNova, Inc. | 71.36M | 0.34% | 52,418 | 257.92K |
| 405 | ATHE | Alterity Therapeutics Limited | 71.21M | -5.56% | 5,975 | 3.57M |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 70.24M | -0.75% | 188,236 | - |
| 407 | LITS | Lite Strategy, Inc. | 69.52M | -1.56% | 199,806 | - |
| 408 | XBIT | XBiotech Inc. | 69.21M | -0.44% | 23,382 | - |
| 409 | NRXP | NRx Pharmaceuticals, Inc. | 68.84M | 4.70% | 143,043 | 242.00K |
| 410 | PYPD | PolyPid Ltd. | 65.87M | 4.21% | 106,136 | - |
| 411 | MGX | Metagenomi, Inc. | 65.71M | 3.55% | 231,284 | 30.91M |
| 412 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 64.72M | 7.66% | 3,968,979 | - |
| 413 | ABVC | ABVC BioPharma, Inc. | 63.88M | 0.75% | 29,576 | 797.92K |
| 414 | OSTX | OS Therapies Incorporated | 63.03M | -3.24% | 63,469 | - |
| 415 | TCRX | TScan Therapeutics, Inc. | 62.99M | - | 579,444 | 8.42M |
| 416 | CALC | CalciMedica, Inc. | 61.53M | 2.44% | 36,366 | - |
| 417 | CVM | CEL-SCI Corporation | 61.31M | 2.13% | 38,122 | - |
| 418 | NTRB | Nutriband Inc. | 59.42M | 1.44% | 10,454 | 2.58M |
| 419 | ALGS | Aligos Therapeutics, Inc. | 58.95M | -2.84% | 26,937 | 2.65M |
| 420 | SNTI | Senti Biosciences, Inc. | 58.63M | 5.69% | 46,186 | - |
| 421 | CELU | Celularity Inc. | 56.66M | -0.25% | 13,200 | 40.58M |
| 422 | EQ | Equillium, Inc. | 54.95M | -10.78% | 392,763 | 4.39M |
| 423 | KRRO | Korro Bio, Inc. | 53.68M | 3.26% | 165,109 | 7.37M |
| 424 | BCAB | BioAtla, Inc. | 53.15M | 6.27% | 1,032,142 | 11.00M |
| 425 | ANL | Adlai Nortye Ltd. | 52.77M | 3.62% | 16,741 | 1.94M |
| 426 | IOBT | IO Biotech, Inc. | 51.77M | -1.96% | 613,428 | - |
| 427 | INKT | MiNK Therapeutics, Inc. | 51.64M | -1.43% | 12,922 | - |
| 428 | JSPR | Jasper Therapeutics, Inc. | 51.49M | 5.44% | 193,106 | - |
| 429 | CUE | Cue Biopharma, Inc. | 49.60M | 2.88% | 31,983 | 7.10M |
| 430 | EVAX | Evaxion A/S | 49.28M | 5.04% | 84,879 | 7.65M |
| 431 | BTAI | BioXcel Therapeutics, Inc. | 49.21M | 8.17% | 688,787 | 752.00K |
| 432 | GNTA | Genenta Science S.p.A. | 48.74M | 7.22% | 95,423 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 48.54M | 2.35% | 170,254 | 1.14M |
| 434 | IPSC | Century Therapeutics, Inc. | 47.61M | 0.98% | 305,752 | 113.34M |
| 435 | NXTC | NextCure, Inc. | 47.44M | 2.71% | 22,072 | - |
| 436 | IBO | Impact BioMedical Inc. | 46.66M | 3.72% | 28,919 | 25.00K |
| 437 | INMB | INmune Bio, Inc. | 46.26M | 5.45% | 515,955 | 50.00K |
| 438 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | 1.52% | 311,024 | - |
| 439 | SER | Serina Therapeutics, Inc. | 45.43M | 8.95% | 17,655 | 116.00K |
| 440 | KZR | Kezar Life Sciences, Inc. | 45.40M | - | 31,845 | - |
| 441 | GRCE | Grace Therapeutics, Inc. | 44.93M | -0.93% | 38,359 | - |
| 442 | ICCC | ImmuCell Corporation | 43.78M | 0.83% | - | 27.77M |
| 443 | MAIA | MAIA Biotechnology, Inc. | 43.70M | 11.32% | 217,360 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 43.05M | -4.83% | 57,736 | 90.00K |
| 445 | PDSB | PDS Biotechnology Corporation | 42.19M | -5.20% | 355,750 | - |
| 446 | JUNS | Jupiter Neurosciences, Inc. | 42.17M | 1.24% | 13,503 | - |
| 447 | SKYE | Skye Bioscience, Inc. | 42.00M | - | 66,721 | - |
| 448 | RNTX | Rein Therapeutics Inc. | 41.27M | 1.95% | 84,525 | - |
| 449 | OKUR | OnKure Therapeutics, Inc. | 41.05M | 5.94% | 60,748 | - |
| 450 | LTRN | Lantern Pharma Inc. | 40.49M | -4.74% | 54,387 | - |
| 451 | RADX | Radiopharm Theranostics Limited | 40.06M | -0.34% | - | 8.20M |
| 452 | VERU | Veru Inc. | 39.80M | 1.64% | 51,493 | 16.89M |
| 453 | XLO | Xilio Therapeutics, Inc. | 39.77M | 1.00% | 108,029 | 31.80M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 38.93M | 3.23% | 74,825 | - |
| 455 | QNTM | Quantum BioPharma Ltd. | 38.39M | -14.99% | 660,505 | - |
| 456 | APLT | Applied Therapeutics, Inc. | 37.52M | -1.59% | 4,566,697 | 1.00M |
| 457 | GBIO | Generation Bio Co. | 35.91M | - | 7,656 | 15.27M |
| 458 | FGEN | FibroGen, Inc. | 35.60M | -0.56% | 12,579 | 8.30M |
| 459 | MURA | Mural Oncology plc | 35.08M | 0.25% | 92,182 | - |
| 460 | KLTO | Klotho Neurosciences, Inc. | 34.47M | 8.04% | 539,635 | - |
| 461 | PLUR | Pluri Inc. | 34.33M | -2.62% | 7,652 | 1.33M |
| 462 | DYAI | Dyadic International, Inc. | 34.27M | 1.27% | 96,570 | 3.34M |
| 463 | RNXT | RenovoRx, Inc. | 33.62M | 3.52% | 155,003 | 928.00K |
| 464 | HYPD | Hyperion DeFi, Inc. | 32.30M | 6.37% | 166,235 | 345.32K |
| 465 | APLM | Apollomics, Inc. | 32.30M | -1.25% | 137,643 | 198.00K |
| 466 | BRNS | Barinthus Biotherapeutics plc | 32.26M | 0.12% | 20,684 | 14.97M |
| 467 | ANTX | AN2 Therapeutics, Inc. | 29.87M | 2.83% | 149,202 | - |
| 468 | NRSN | NeuroSense Therapeutics Ltd. | 29.80M | 1.71% | 70,830 | - |
| 469 | IGC | IGC Pharma, Inc. | 29.63M | -0.09% | 293,852 | 1.11M |
| 470 | NRXS | NeurAxis, Inc. | 29.61M | 4.12% | 29,041 | 3.36M |
| 471 | NERV | Minerva Neurosciences, Inc. | 29.23M | 8.73% | 36,630 | - |
| 472 | LIMN | Liminatus Pharma, Inc. | 28.15M | 6.55% | 305,105 | - |
| 473 | PASG | Passage Bio, Inc. | 28.07M | -0.67% | 18,478 | - |
| 474 | CLGN | CollPlant Biotechnologies Ltd. | 27.95M | -1.89% | 13,447 | 2.48M |
| 475 | IBIO | iBio, Inc. | 27.66M | 2.50% | 445,583 | 500.00K |
| 476 | LNAI | Lunai Bioworks Inc. | 27.65M | -8.53% | 547,486 | - |
| 477 | RLYB | Rallybio Corporation | 27.50M | 1.26% | 53,751 | 674.00K |
| 478 | QTTB | Q32 Bio Inc. | 26.95M | - | 65,013 | - |
| 479 | XCUR | Exicure, Inc. | 26.64M | 8.29% | 11,005 | 500.00K |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 26.60M | 2.86% | 539,283 | - |
| 481 | DARE | Daré Bioscience, Inc. | 26.29M | 1.66% | 37,176 | -57.13K |
| 482 | BOLD | Boundless Bio, Inc. | 26.19M | 4.50% | 89,780 | - |
| 483 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 25.40M | -10.47% | 418,254 | 1.00M |
| 484 | CING | Cingulate Inc. | 25.20M | 1.63% | 152,848 | - |
| 485 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.36M | 3.09% | 130,511 | - |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 24.31M | 3.67% | 41,090 | 15.65M |
| 487 | ITRM | Iterum Therapeutics plc | 24.28M | -1.94% | 562,344 | 390.00K |
| 488 | LEXX | Lexaria Bioscience Corp. | 24.23M | -2.68% | 61,495 | 705.92K |
| 489 | INTS | Intensity Therapeutics, Inc. | 23.98M | 0.76% | 733,466 | - |
| 490 | GLTO | Galecto, Inc. | 23.60M | 2.24% | 150,761 | - |
| 491 | ENLV | Enlivex Therapeutics Ltd. | 23.56M | 7.77% | 1,222,147 | - |
| 492 | APVO | Aptevo Therapeutics Inc. | 23.25M | 7.81% | 551,794 | - |
| 493 | PTN | Palatin Technologies, Inc. | 22.39M | 15.08% | 29,573 | 8.85M |
| 494 | NNVC | NanoViricides, Inc. | 21.96M | -3.17% | 92,557 | - |
| 495 | TRAW | Traws Pharma, Inc. | 21.58M | 5.47% | 83,070 | 2.85M |
| 496 | GDTC | CytoMed Therapeutics Limited | 21.46M | -2.16% | 4,250 | 573.19K |
| 497 | CASI | CASI Pharmaceuticals, Inc. | 20.96M | 1.98% | 36,160 | 26.85M |
| 498 | MRKR | Marker Therapeutics, Inc. | 20.67M | 1.64% | 242,413 | 4.69M |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 19.49M | 0.11% | 10,255 | - |
| 500 | KZIA | Kazia Therapeutics Limited | 19.36M | 5.92% | 46,693 | 1.20M |
| 501 | ALLR | Allarity Therapeutics, Inc. | 19.32M | 6.40% | 120,637 | - |
| 502 | BCTX | BriaCell Therapeutics Corp. | 19.19M | -5.54% | 55,115 | - |
| 503 | LPCN | Lipocine Inc. | 19.10M | 4.88% | 21,006 | 4.32M |
| 504 | OSRH | OSR Holdings, Inc. | 19.10M | 9.56% | 1,286,777 | -90.52K |
| 505 | MTVA | MetaVia Inc. | 18.84M | 3.71% | 400,579 | - |
| 506 | HOTH | Hoth Therapeutics, Inc. | 18.77M | 1.25% | 46,883 | - |
| 507 | ABP | Abpro Holdings, Inc. | 18.47M | -2.64% | 10,379 | 183.00K |
| 508 | NCEL | NewcelX Ltd. | 18.28M | 4.05% | 35,988 | - |
| 509 | LSTA | Lisata Therapeutics, Inc. | 17.99M | -0.49% | - | 1.07M |
| 510 | NCNA | NuCana plc | 17.81M | 7.81% | 78,598 | - |
| 511 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.81M | 2.46% | 46,021 | - |
| 512 | CRIS | Curis, Inc. | 17.71M | 9.60% | 117,596 | 11.65M |
| 513 | AKTX | Akari Therapeutics, Plc | 17.38M | 9.06% | 59,746 | - |
| 514 | KAPA | Kairos Pharma, Ltd. | 17.36M | 12.66% | 89,429 | - |
| 515 | ATHA | Athira Pharma, Inc. | 17.16M | 0.41% | - | - |
| 516 | SYBX | Synlogic, Inc. | 17.08M | -11.52% | 145,679 | 8.00K |
| 517 | FBLG | FibroBiologics, Inc. | 16.79M | -0.29% | 1,008,554 | - |
| 518 | PULM | Pulmatrix, Inc. | 16.25M | 0.22% | - | 3.00K |
| 519 | SNGX | Soligenix, Inc. | 16.04M | 8.16% | 392,953 | 2.34K |
| 520 | CMMB | Chemomab Therapeutics Ltd. | 16.00M | 2.77% | 54,378 | - |
| 521 | CANF | Can-Fite BioPharma Ltd. | 15.69M | 4.40% | 849,845 | 560.00K |
| 522 | BCDA | BioCardia, Inc. | 15.39M | - | 69,099 | 3.00K |
| 523 | CLRB | Cellectar Biosciences, Inc. | 15.22M | 3.77% | 38,628 | - |
| 524 | DWTX | Dogwood Therapeutics, Inc. | 14.95M | - | 14,488 | - |
| 525 | PCSA | Processa Pharmaceuticals, Inc. | 14.67M | 3.02% | 404,883 | - |
| 526 | COCP | Cocrystal Pharma, Inc. | 14.61M | 4.95% | 47,617 | - |
| 527 | PMN | ProMIS Neurosciences, Inc. | 14.55M | -9.67% | 82,545 | - |
| 528 | BLRX | BioLineRx Ltd. | 14.39M | 0.73% | 9,702 | 12.74M |
| 529 | TPST | Tempest Therapeutics, Inc. | 14.21M | -0.31% | 159,470 | - |
| 530 | LGVN | Longeveron Inc. | 14.16M | 2.50% | 507,207 | 1.44M |
| 531 | MBRX | Moleculin Biotech, Inc. | 13.88M | -2.61% | 2,233,932 | - |
| 532 | PHIO | Phio Pharmaceuticals Corp. | 13.56M | 2.44% | 92,007 | - |
| 533 | VYNE | VYNE Therapeutics Inc. | 12.83M | 2.50% | 371,540 | 524.00K |
| 534 | IMNN | Imunon, Inc. | 12.65M | 6.74% | 22,386 | - |
| 535 | GOVX | GeoVax Labs, Inc. | 12.21M | 2.77% | 257,713 | 3.35M |
| 536 | EDSA | Edesa Biotech, Inc. | 12.03M | - | 12,840 | - |
| 537 | PPCB | Propanc Biopharma, Inc. | 11.94M | 10.96% | 60,542 | - |
| 538 | IMRN | Immuron Limited | 11.62M | -2.57% | 7,980 | 4.78M |
| 539 | ICU | SeaStar Medical Holding Corporation | 11.41M | 4.01% | 1,667,410 | 881.00K |
| 540 | ASBP | Aspire Biopharma Holdings, Inc. | 11.36M | 1.63% | 9,779,268 | 1.94K |
| 541 | BIVI | BioVie Inc. | 11.31M | 3.45% | 65,263 | - |
| 542 | CLDI | Calidi Biotherapeutics, Inc. | 11.05M | 2.03% | 31,568 | - |
| 543 | APM | Aptorum Group Limited | 10.99M | 0.75% | 19,703 | - |
| 544 | KTTA | Pasithea Therapeutics Corp. | 10.94M | 38.68% | 166,264,382 | - |
| 545 | SNSE | Sensei Biotherapeutics, Inc. | 10.62M | -1.18% | 5,177 | - |
| 546 | ERNA | Ernexa Therapeutics Inc. | 10.60M | -4.35% | 15,776 | 1,000.00 |
| 547 | MBIO | Mustang Bio, Inc. | 10.29M | 13.71% | 308,195 | - |
| 548 | ENTO | Entero Therapeutics, Inc. | 10.05M | 5.28% | 896,840 | - |
| 549 | CELZ | Creative Medical Technology Holdings, Inc. | 9.94M | 0.75% | 11,783 | 6.00K |
| 550 | AEON | AEON Biopharma, Inc. | 9.86M | 1.32% | 31,914 | - |
| 551 | EVGN | Evogene Ltd. | 9.75M | -3.96% | 64,510 | 8.02M |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 9.73M | 2.42% | - | 5.20M |
| 553 | BRTX | BioRestorative Therapies, Inc. | 9.57M | -1.94% | 12,189 | 383.40K |
| 554 | INAB | IN8bio, Inc. | 9.18M | -1.49% | 19,420 | - |
| 555 | TOVX | Theriva Biologics, Inc. | 9.11M | 4.86% | 1,304,328 | - |
| 556 | RNAZ | TransCode Therapeutics, Inc. | 8.52M | 2.49% | 1,211 | - |
| 557 | GTBP | GT Biopharma, Inc. | 8.40M | -1.46% | 258,339 | - |
| 558 | ALZN | Alzamend Neuro, Inc. | 8.33M | -2.23% | 50,465 | - |
| 559 | ACXP | Acurx Pharmaceuticals, Inc. | 8.09M | 3.47% | 11,130 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 8.01M | 1.60% | 18,438 | 488.24K |
| 561 | KALA | KALA BIO, Inc. | 7.93M | 6.12% | 4,056,837 | - |
| 562 | ADXN | Addex Therapeutics Ltd | 7.75M | -3.97% | - | 210.35K |
| 563 | XTLB | XTL Biopharmaceuticals Ltd. | 7.56M | 4.40% | - | 451.00K |
| 564 | ADIL | Adial Pharmaceuticals, Inc. | 7.52M | 1.16% | 298,765 | - |
| 565 | TCRT | Alaunos Therapeutics, Inc. | 7.45M | -4.76% | 21,486 | 6.00K |
| 566 | BGMS | Bio Green Med Solution, Inc. | 7.40M | 3.33% | 18,993 | 81.00K |
| 567 | KPRX | Kiora Pharmaceuticals, Inc. | 7.26M | 5.32% | 40,772 | 20.00K |
| 568 | PHGE | BiomX Inc. | 6.66M | -7.23% | 55,891 | - |
| 569 | PPBT | Purple Biotech Ltd | 6.64M | 4.09% | 143,557 | - |
| 570 | LYRA | Lyra Therapeutics, Inc. | 6.55M | 1.14% | 44,093 | 600.00K |
| 571 | GRI | GRI Bio, Inc. | 6.54M | 1.01% | 145,761 | - |
| 572 | PLRZ | Polyrizon Ltd. | 6.34M | 2.81% | 127,697 | - |
| 573 | ENSC | Ensysce Biosciences, Inc. | 6.27M | - | 51,399 | 4.49M |
| 574 | SILO | Silo Pharma, Inc. | 6.19M | 3.31% | 44,539 | 72.10K |
| 575 | XBIO | Xenetic Biosciences, Inc. | 6.03M | 1.94% | 36,727 | 2.86M |
| 576 | CYCN | Cyclerion Therapeutics, Inc. | 6.01M | 5.26% | 25,922 | 2.86M |
| 577 | VIVS | VivoSim Labs, Inc. | 5.84M | 4.12% | 17,574 | 140.00K |
| 578 | HCWB | HCW Biologics Inc. | 5.73M | 9.74% | 50,012 | 422.03K |
| 579 | REVB | Revelation Biosciences, Inc. | 5.66M | 2.36% | 46,605 | - |
| 580 | JAGX | Jaguar Health, Inc. | 5.53M | 5.47% | 50,167 | 11.79M |
| 581 | SLRX | Salarius Pharmaceuticals, Inc. | 5.51M | 1.62% | 277,348 | - |
| 582 | PMCB | PharmaCyte Biotech, Inc. | 5.26M | -6.07% | 580,258 | - |
| 583 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.22M | -2.75% | - | 15.78K |
| 584 | GLMD | Galmed Pharmaceuticals Ltd. | 5.15M | 1.74% | 103,984 | - |
| 585 | GNPX | Genprex, Inc. | 4.83M | 3.45% | 74,721 | - |
| 586 | MTNB | Matinas BioPharma Holdings, Inc. | 4.80M | 2.74% | 32,335 | - |
| 587 | ONCO | Onconetix, Inc. | 4.34M | 19.31% | 89,225 | 1.22M |
| 588 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.32M | -2.86% | 35,985 | 1.36M |
| 589 | CNSP | CNS Pharmaceuticals, Inc. | 4.30M | 2.97% | 1,993 | - |
| 590 | XRTX | XORTX Therapeutics Inc. | 4.21M | 4.08% | 69,583 | - |
| 591 | PTIX | Protagenic Therapeutics, Inc. | 4.12M | -5.38% | 128,740 | - |
| 592 | ELAB | PMGC Holdings Inc. | 3.95M | -0.76% | - | -241.53K |
| 593 | INDP | Indaptus Therapeutics, Inc. | 3.91M | - | 49,119 | - |
| 594 | AZTR | Azitra, Inc. | 3.85M | 5.63% | 289,135 | 7.50K |
| 595 | OGEN | Oragenics, Inc. | 3.63M | -4.40% | 65,833 | - |
| 596 | SPRC | SciSparc Ltd. | 3.57M | -0.90% | 432,494 | 1.31M |
| 597 | ARTL | Artelo Biosciences, Inc. | 3.51M | 4.82% | 22,472 | - |
| 598 | ENVB | Enveric Biosciences, Inc. | 3.43M | 1.47% | - | - |
| 599 | CDT | CDT Equity Inc. | 3.31M | -1.93% | 4,251,885 | - |
| 600 | SCNI | Scinai Immunotherapeutics Ltd. | 3.28M | 5.78% | 52,886 | 1.15M |
| 601 | DRMA | Dermata Therapeutics, Inc. | 3.22M | 3.63% | 8,575 | - |
| 602 | PBM | Psyence Biomedical Ltd. | 2.87M | -2.85% | 102,944 | - |
| 603 | BDRX | Biodexa Pharmaceuticals Plc | 2.81M | 3.62% | - | 104.90K |
| 604 | CLSD | Clearside Biomedical, Inc. | 2.15M | -26.96% | 2,768,773 | 3.33M |
| 605 | ADTX | Aditxt, Inc. | 2.13M | 21.02% | 24,956,869 | 5.95K |
| 606 | VRAX | Virax Biolabs Group Limited | 1.75M | 1.02% | 80,982 | 6.33K |
| 607 | MLEC | Moolec Science SA | 1.61M | -2.34% | 53,157 | 7.83M |
| 608 | SLXN | Silexion Therapeutics Corp | 1.59M | -2.08% | 35,972 | - |
| 609 | CMND | Clearmind Medicine Inc. | 981.93K | -0.32% | 4,137,033 | - |